AU2002309477A1 - Compositions, methods and apparatuses for singlet oxygen delivery - Google Patents

Compositions, methods and apparatuses for singlet oxygen delivery

Info

Publication number
AU2002309477A1
AU2002309477A1 AU2002309477A AU2002309477A AU2002309477A1 AU 2002309477 A1 AU2002309477 A1 AU 2002309477A1 AU 2002309477 A AU2002309477 A AU 2002309477A AU 2002309477 A AU2002309477 A AU 2002309477A AU 2002309477 A1 AU2002309477 A1 AU 2002309477A1
Authority
AU
Australia
Prior art keywords
apparatuses
compositions
methods
singlet oxygen
oxygen delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002309477A
Inventor
Randolph M. Howes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002309477A1 publication Critical patent/AU2002309477A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002309477A 2001-01-22 2002-01-18 Compositions, methods and apparatuses for singlet oxygen delivery Abandoned AU2002309477A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26263501P 2001-01-22 2001-01-22
US60/262,635 2001-01-22
PCT/US2002/000513 WO2002078718A2 (en) 2001-01-22 2002-01-18 Compositions, methods and apparatuses for singlet oxygen delivery

Publications (1)

Publication Number Publication Date
AU2002309477A1 true AU2002309477A1 (en) 2002-10-15

Family

ID=22998355

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002309477A Abandoned AU2002309477A1 (en) 2001-01-22 2002-01-18 Compositions, methods and apparatuses for singlet oxygen delivery

Country Status (5)

Country Link
EP (1) EP1353679A2 (en)
JP (1) JP2004524356A (en)
AU (1) AU2002309477A1 (en)
CA (1) CA2435390A1 (en)
WO (1) WO2002078718A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000341A1 (en) * 2003-06-25 2005-01-06 Vib Vzw Use of cytosolic phospholipid hydroperoxide glutathione peroxidase to reduce tumor growth
US20050281890A1 (en) * 2004-06-18 2005-12-22 San Chandan K Methods and compositions for wound healing
CN103432581A (en) * 2013-03-22 2013-12-11 北京海思威科技有限公司 Application of carbamide peroxide injection in inactivation of viruses for treating diseases
WO2014196201A1 (en) * 2013-06-07 2014-12-11 パナソニックIpマネジメント株式会社 Tooth bleaching device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756090A (en) * 1991-02-21 1998-05-26 Eoe, Inc. Oxygen activatable formulations for disinfection or sterilization
DE4137544C2 (en) * 1991-11-12 1998-07-30 Kramer Axel Antimicrobial combination of active ingredients based on oxygen-releasing compounds
JPH06206825A (en) * 1992-12-11 1994-07-26 Nippon Rooshiyon Kk Agent for treatment of dermatosis caused by trichophyton, eczema, etc., and agent for skin disinfection and activation
JP3023356B1 (en) * 1998-12-28 2000-03-21 株式会社生体光情報研究所 Erasing agent erasing ability judgment method

Also Published As

Publication number Publication date
WO2002078718A2 (en) 2002-10-10
CA2435390A1 (en) 2002-10-10
JP2004524356A (en) 2004-08-12
EP1353679A2 (en) 2003-10-22
WO2002078718A3 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
AU2003304420A1 (en) Compositions, methods, apparatuses, and systems for singlet oxygen delivery
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2001285143A1 (en) Methods and compositions for targeted delivery
AU2002352755A1 (en) Streamed content delivery
AU2003270015A1 (en) Compounds, compositions, and methods
EP1440550B8 (en) Methods for multicasting content
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003299612A1 (en) Compounds, compositions and methods
AU2002360759A1 (en) Polyether carbamate compounds, compositions containing such compounds, and methods related thereto
AU2003284387A1 (en) Delivery composition and method
AUPR851701A0 (en) Seating apparatus
AU2002256995A1 (en) Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
AU2002306968A1 (en) Ogri gene disruptions, compositions and methods relating thereto
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001238485A1 (en) Methods and compositions for gene delivery
AU2002353780A1 (en) Mo54 gene disruptions, compositions and methods related thereto
EP1411897A4 (en) Compositions and methods for intracellular delivery
AU2002309477A1 (en) Compositions, methods and apparatuses for singlet oxygen delivery
AU2002301057A1 (en) Humidified Gases Delivery Apparatus
AU2634701A (en) Oxygen delivery apparatus
AU2003267169A1 (en) Compounds, compositions and methods
AU2003300031A1 (en) Compounds, compositions, and methods
AU2002350181A1 (en) Compositions and methods for viral delivery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase